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September 2014 signaling in endothelial cells. Moreover, the high level of heterogeneity within endothelial cells and apparent context dependency of BMP signaling outcomes further complicates the interpretation of the function of BMP signaling in endothelial cells. 1 In this review, we aim to provide a comprehensive overview on the effects of BMP signaling in diverse settings to highlight the heterogeneity of endothelial cells.
Nuts and Bolts of BMP Signaling
BMPs represent the largest subgroup of the transforming growth factor-β superfamily proteins, which are essential for diverse biological processes including axis formation, osteogenesis, stem cell maintenance, and iron metabolism. 27 BMPs are expressed as large precursor proteins of 400 to 500 amino acids which contain an N-terminal signal peptide domain, a prodomain for proper folding, and a C-terminal mature growth factor domain. 28 Unlike structurally related transforming growth factor-β superfamily proteins which are secreted as latent complexes, most BMPs, with the exceptions of BMP7 and BMP9, are secreted in a mature ligand form dissociated from the prodomain by endoproteolytic cleavage. [29] [30] [31] To date, >20 BMP ligands, 4 type I BMP receptors (BMPRIs), 3 type II BMP receptors, and several coreceptors have been identified and characterized in the mammalian system. 32 Once secreted, BMPs readily form a homodimer via a disulfide bond which leads to stabilization of dimeric ligands. 33, 34 Although BMPs generally form homodimeric ligands, recent studies suggest that heterodimeric BMP ligands can induce more robust downstream activation than homodimeric BMP ligands. [35] [36] [37] [38] [39] Although BMP ligands can be divided into 4 subgroups, the BMP2/4 subgroup, the growth and differentiation (GDF)5/6/7 group, the BMP5/6/7/8 group, and the BMP 9/10 group, based on their amino acid sequence similarity, 29, 40 each BMP ligand interacts differently with receptors (as reviewed in depth in) 28, 29 and elicits distinct cellular responses. During development, the gradient of BMP ligands is modulated by a diverse group of secreted BMP antagonists, [41] [42] [43] [44] [45] [46] [47] [48] [49] which form disulfide bonds with BMP ligands to interfere with the ligandreceptor interaction. 50 On the surface of the signal receiving cells, dimeric BMP ligands induce formation of a stable tetraheteromeric receptor complex consisting of 2 BMPRIs and 2 type II BMP receptors. 51 To date, ≥4 type I receptors, activin type I receptor like 1/ALK1, activin type I receptor/ALK2, BMPRIA/ALK3, and BMPRIB/ALK6, and 3 type II receptors, type II BMP receptor, ACTRIIA, and ACTRIIB, with similar structural motifs have been identified. 52 The type II receptor kinase is constitutively active in the absence of a ligand. 53 Although it has been suggested that type I and type II receptors can exist as a preformed complex, the presence of a ligand facilitates the formation of the receptor complex. [54] [55] [56] In addition to the type I and type II receptors, BMPs can interact with diverse surface proteins on the cell, which modulate signaling outcomes. 57, 58 On binding to their cognate receptor complex, BMPs elicit diverse cellular responses by regulating downstream effectors ( Figure 2 ).
Arguably, the most well-characterized downstream effectors of BMP signaling are R-SMADs (SMAD1, 5, and 8). 59 These receptor-activated R-SMADs are released from the receptor complex to form a heterotrimeric complex of 2 R-SMADs and a co-SMAD (SMAD4) which has increased nuclear import rates. This process is frequently regulated by additional factors such as SMAD6 and PRMT1. 60 After translocation into the nucleus, they regulate target gene expression by directly binding to SMAD-binding elements, indirectly through interactions with DNA-binding transcription factors, or by associating with coactivators/corepressors and histonemodifying factors. 53 For instance, SMADs are known to induce the expression of Id genes, 61,62 cyclooxygenase 2 (Cox2), 63 Myo10 (an atypical myosin critical for filopodial formation), 64 and miRNAs ( Figure 2 ). [65] [66] [67] In addition, BMP signaling seems to activate cell type-specific targets. For example, expression of apelin and its cognate receptor APJ in pulmonary arterial endothelial cells 68, 69 and expression of VEGF-A in osteoblast 70 (1) . A subset of BMP ligands, notably BMP9, intersects with Notch/DLL4 signaling to induce a distinct group of target genes (3), in addition to initiating the transcription of their own target genes (2) . AEC indicates arterial endothelial cells; EPC, endothelial progenitor cells; S, stalk cell; T, tip cell; and VEC, venous endothelial cells. JNK, LIMK, cofilin, AKT, PKC, TcTex, and a variety of Rho-GTPases signaling pathways. [71] [72] [73] [74] [75] [76] However, because of a large number of possible combinations of ligands, receptors, and antagonists, the detailed roles and the mechanism of activation in SMAD-independent responses in endothelial cells remain largely elusive.
Jack of All Trades? Diverse Functions of BMP Signaling in Endothelial Cells
As its name indicates, BMP was first identified as the key regulator that promotes the formation of bone. 77 Over the past 3 decades since their identification, it has become apparent that BMPs are not only limited to the regulation of bone formation but are indispensable for diverse biological processes including patterning and differentiation of various embryonic structures and maintenance of adult tissue homeostasis. 34, 78 Therefore, it may be more appropriate to consider BMPs as body morphogenesis proteins instead of BMPs. 79 Consistent with this idea, BMPs have been shown to play essential roles in regulating differentiation and morphogenesis of endothelial cells. 80, 81 During early developmental stages, BMPs are indispensable for induction of the mesoderm where endothelial cells will originate. 82, 83 BMPs also provide key inputs during the patterning of the lateral plate mesoderm and subsequent differentiation of endothelial cells from the lateral plate mesoderm. Perturbations of BMP activity alter the stoichiometry among lateral plate mesoderm-derived cell types, including endothelial cells. For example, ectopic expression of dominant negative Bmpr1a/Alk3 (DN-Bmpr1a) causes increased hemato-vascular precursors, suggesting that BMP activity negatively regulates the emergence of endothelial cells in zebrafish, 84 illustrating the importance of BMP signaling in differentiation of endothelial cells. During subsequent morphogenesis, intricate interactions between BMP ligands and their endogenous inhibitors dictate the patterning of developing vessels. [85] [86] [87] For instance, inhibition of BMP signaling in the midline by notochord-derived Noggin creates an avascular region adjacent to the notochord. 87 In addition, chordin, another BMP antagonist, has been shown to modulate the fusion of dorsal aortae in avian models. 85 In mouse, conditional inactivation of BMPRIs or type II BMP receptor within endothelial cells in mice leads to various defects during development. For instance, in mice, deletion of Alk2 or Alk3 in endothelial cells disrupts the formation of cardiac valves, 88, 89 deletion of BMPER, a context-dependent modulator of BMP signaling, causes failure of coronary vessel remodeling, 90 and a lack of BMPR2 in endothelial cells predisposes pulmonary hypertension. 91 Similarly, in zebrafish, a lack of alk3a or alk3b causes severe disruption in cardiovascular development, 92, 93 and mutations in alk1 causes failure in cranial vessel remodeling. 94 More recently, it has been shown that BMP signaling also regulates the emergence of lymphatic endothelial cells during development. During development, BMP2 seems to function as an antilymphangiogenic agent by inducing expression of miRNAs which in turn negatively regulate the stability of Prox1 mRNA. 66 In contrast, BMP9 seems to provide prolymphangiogenic cues during development. 95 Figure 2 . Diverse effects of bone morphogenetic protein (BMP) signaling in endothelial cells. BMP ligands function as dimers, and their gradient is regulated by extracellular antagonists. The ligands bind to heterotetrameric receptor complexes whose function is modulated by type III receptors. Activated BMP receptors can elicit diverse cellular responses including cytoskeletal rearrangement and initiation of target gene transcription via SMAD1/5/8 and MAPKs. Within the signaling receiving cells, the amplitude of the BMP signaling response can be modulated by additional factors such as SMAD6 and PRMT1.
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As shown in other vertebrates, mutations of various BMP signaling components have been linked to various pathological conditions that cause vascular dysfunction and diseases such as hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH) in humans. HHT, also known as Osler-Weber-Rendu disease, is a genetic disorder that leads to abnormal blood vessel formation in the skin, mucous membranes, and often in organs such as the lungs, liver, and brain. 96 HHT type 1 results from pathogenic mutations in ENG that causes haploinsufficiency of endoglin, 97 whereas HHT type 2 is caused by a loss of function or dominant negative mutations in ALK1. 98 Similarly, genetic manipulation of endoglin and ALK1 in mice mirrors many of the characteristics of HHT. [99] [100] [101] [102] PAH is an increase in blood pressure in the pulmonary artery leading to shortness of breath, dizziness, fainting, leg swelling, and can even lead to heart failure. The principal gene associated with PAH is BMPR2. Loss of function in BMPR2 is found in >70% of patients with hereditary PAH and 20% of patients with idiopathic PAH. 103, 104 Mutations in various regions of BMPR2 including the ligand-binding domain, the kinase domain, and the long cytoplasmic tail may be associated with PAH. Among them, the long cytoplasmic tail region might play an important role in PAH because mice expressing a smooth muscle-specific BMPR2 tail deleted mutation show pulmonary vascular pruning leading to elevated right ventricular systolic pressures, which is associated with PAH. 105 The tail region is known to regulate p38 and p42/44 MAPK signaling, but until recently, little was known about how these signals are developed. 106, 107 In addition, many other BMP components are also known to be related to vascular diseases such as HHT and PAH. 29 It is apparent that BMP signaling provides an essential function in modulating development and maintenance of endothelial cells.
BMP Signaling in Venous Vascular Beds
During development, venous fate is often considered the default status. Although arterial cells must undergo differentiation processes orchestrated by multiple signaling cascades, including Hedgehog, 108 VEGF, 108 Notch, 108 and EphrinB2 signaling, 109 and transcription factors, such as Forkhead box C1 and C2 (Foxc1/2), 110 it is unclear how venous fate is determined. To date, COUP-TFII, an orphan nuclear receptor, is the only factor that is implicated as essential for the specification of venous endothelial cells. 111 Moreover, the majority of widely used venous markers such as EphB4, Dab2, and NRP2 are gradually restricted to venous endothelial cells during development and therefore are not bona fide markers at early stages, 3, 112, 113 which further complicates the analyses of the specification of venous endothelial cells in early development.
However, this concept was challenged by a series of reports which collectively present a scenario, whereby venous endothelial cells are derived from a unique subset of endothelial progenitors during development. First, venous endothelial cells seem to undergo distinct morphogenetic processes to form the axial vein in zebrafish. 114 More recently, a similar observation was reported in mouse embryos. 115 More definite evidence indicating that venous endothelial cells may not be the default fate of endothelial cells came from lineage tracing experiments in zebrafish. This new evidence indicates that progenitors for venous endothelial cells are localized to a distinct area in developing embryos. 116 Compared with the arterial endothelial progenitors which are preferentially located more medially within the lateral plate mesoderm, venous endothelial progenitors seem to be located laterally even in early developmental stages in zebrafish. 116 Moreover, only arterial endothelial progenitors, not venous endothelial progenitors, migrate medially in response to VEGF and Hedgehog signaling activities forming the dorsal aorta, indicating that the signaling that governs the behaviors of venous endothelial progenitors may also be distinct.
We have previously shown that BMP2 signaling provides a venous specific cue for sprouting angiogenesis. 117 Manipulation of BMP2 signaling during early vascular development causes severe disruption in the formation of the cardinal vein plexus, the vascular beds generated by sprouting angiogenesis of the cardinal vein. 117 In addition, an excessive level of BMP2 signaling in zebrafish embryos leads to the formation of exuberant angiogenic sprouts from venous endothelial cells in the cardinal vein, whereas arterial endothelial cells in the adjacent dorsal aorta do not respond to BMP2 signaling. Interestingly, VEGF-A signaling does not seem to be essential for the morphogenesis of venous vascular beds in zebrafish. Although attenuation of VEGF-A signaling increases apoptosis in venous endothelial cells, it does not cause discernible changes in venous morphogenesis. Moreover, only arterial endothelial cells, but not venous endothelial cells, undergo sprouting angiogenesis in response to ectopic expression of VEGF-A signaling (Figure 3 ). 117 Taken together, it seems that BMP2 signaling, not VEGF-A signaling, provides the major morphogenetic cue within venous vascular beds in zebrafish. How does BMP signaling preferentially activate venous endothelial cells without affecting arterial endothelial cells in zebrafish? Previous reports suggest that venous endothelial cells in zebrafish may be innately sensitized to BMP signaling. First of all, both orthologs of BMPR2 in zebrafish, bmpr2a and bmpr2b, are enriched in venous endothelial cells during development, possibly increasing venous endothelial cells sensitivity to BMP signaling. 117, 118 Moreover, a cargospecific adaptor, Dab2, whose function is essential to induce phosphorylation of SMADs, 113 is preferentially expressed in venous endothelial cells in zebrafish. 119 Therefore, it is conceivable that availability of Dab2, Bmpr2a, and Bmpr2b may restrict cellular responses to BMP signaling in venous endothelial cells. Consistent with this idea, venous endothelial cells in zebrafish contain substantially higher levels of BMP responsive element:EGFP reporter expression compared with arterial endothelial cells. In contrast, arterial endothelial cells have a higher activity of Notch which may suppress responses to BMP signaling. Consistent with this idea, we have recently found that venous endothelial cells are largely devoid of Notch activity and ectopic activation of Notch in venous endothelial cells abrogates sprouting angiogenesis of veins in response to BMP signaling, hinting at an antagonistic interaction between Notch and BMP2 signaling in this setting. Even within venous vascular beds, the BMP responsive element:EGFP reporter expression, as well as activity of phospho-SMAD, seems to be highly heterogeneous, suggesting that individual venous endothelial cells may respond to BMP signaling at different amplitudes ( Figure 4 ). 113 Considering that it is still not clear how venous vascular beds undergo sprouting angiogenesis, further analyses on the role of proangiogenic BMP signaling in tip/stalk cell selection in venous endothelial cells may help us to unravel complex interactions among major signaling inputs in this process.
Beyond Venous Vascular Beds
Beyond developmental stages, BMP signaling also provides critical functions for vascular homeostasis in postnatal stages. During wound healing, it has been shown that BMP signaling is highly upregulated in keratinocytes, fibroblasts, and macrophages within the vicinity of wounds. 120 In addition, BMP signaling has been implicated in angiogenesis associated with pathological conditions. For instance, expression of BMP ligands is often elevated with a concomitant decrease of BMP antagonists in renal cancer. 121, 122 Considering that treatments with VEGF inhibitors, such as Sorafenib (tyrosine kinase inhibitor) and Bevacizumb (monoclonal antibody for VEGF), do not provide significant long-term improvements for patients with tumor, other proangiogenic pathways such as BMP may compensate for the loss of VEGF signaling. 123 Interestingly, the outcomes of BMP signaling are highly context dependent and can reflect the innate differences among endothelial cells (ie, tumor associated versus normal endothelial cells). 124 Further analyses on the functions of BMP signaling within endothelial cells will enable us to develop therapeutic applications to target BMP signaling specifically in tumor-associated endothelial cells. Targeting VEGF-A has been shown to be problematic because it is essential for the survival of all endothelial cells. Therefore, targeting BMP signaling, which exerts context-dependent effects in endothelial cells, may dampen the side effects of antiangiogenic therapy while increasing the efficacy of treatment in patients with tumor.
Because of a large number of ligands and receptors, and their promiscuous interactions, the effects of BMP signaling in endothelial cells are described as highly context dependent. Inconsistent and often contradictory results among published reports further complicate the analyses on the effects of BMP signaling. Because we have just begun to interrogate diverse functions of BMP signaling in endothelial cells, detailed and comprehensive analyses on the function of BMP signaling may help us to clear up confusion and misinterpretations and suggest a more refined model of how BMP signaling works in endothelial cells which accurately describe context dependency of the signaling outcomes. For instance, it is currently unknown how pro-and antiangiogenic BMP signaling, both of which rely on SMADs activity, can be distinguished in signaling receiving endothelial cells. Moreover, with a notable exception with Notch and BMP signaling interaction, 125, 126 it is not clear how BMP signaling intersects Endothelial cells with active BMP signaling seem to localize preferentially to the tip cell position within venous angiogenic sprouts (white arrows), whereas those with inactive BMP signaling (asterisks) assume the stalk cell position within venous angiogenic sprouts, hinting the link between high BMP signaling activity and venous tip cell in this specific vascular bed. B, Schematic illustration of sprouting angiogenesis in arterial and venous endothelial cells. In arterial endothelial cells, the vascular endothelial growth factor-A gradient functions as the key factor to specify tip cells (T) and stalk cells (S). BMP signaling may exert a similar function in venous endothelial cells. VEGFR indicates vascular endothelial growth factor receptor.
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